Srivastava Sapna
Insider CIK 1569226 · INVA Director · MYOS Director · AURA Director · SQZ Director · TALS Director · ALMS Director · NUVL Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-15 | 4,147 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-15 | 68,500 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-15 | 20,000 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-15 | 15,000 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-15 | 3,789 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | U Tender | 2026-07-15 | 2026-07-15 | 5,146 | $124.00 | $638.1K | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer | 2026-07-15 | 2026-07-15 | 3,444 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2026-06-30 | 2026-07-02 | 15,528 | — | $0 | 15,528 | SEC↗ |
| ALMS ALUMIS INC. | A Award | 2026-06-30 | 2026-07-02 | 3,553 | — | $0 | 3,553 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award | 2026-06-16 | 2026-06-18 | 3,444 | — | $0 | 8,590 | SEC↗ |
| AURA Aura Biosciences, Inc. | A Award deriv | 2026-06-11 | 2026-06-15 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AURA Aura Biosciences, Inc. | A Award | 2026-06-11 | 2026-06-15 | 15,000 | — | $0 | 38,500 | SEC↗ |
| TRML Tourmaline Bio, Inc. | D To issuer deriv | 2025-10-28 | 2025-10-28 | 10,000 | — | $0 | 0 | SEC↗ |
| TRML Tourmaline Bio, Inc. | D To issuer deriv | 2025-10-28 | 2025-10-28 | 20,000 | — | $0 | 0 | SEC↗ |
| TRML Tourmaline Bio, Inc. | D To issuer deriv | 2025-10-28 | 2025-10-28 | 16,800 | — | $0 | 0 | SEC↗ |
| TRML Tourmaline Bio, Inc. | U Tender | 2025-10-28 | 2025-10-28 | 518 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2025-07-30 | 2025-08-01 | 49,800 | — | $0 | 49,800 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award deriv | 2025-06-18 | 2025-06-20 | 4,147 | — | $0 | 4,147 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award | 2025-06-18 | 2025-06-20 | 2,647 | — | $0 | 5,146 | SEC↗ |
| AURA Aura Biosciences, Inc. | A Award deriv | 2025-06-17 | 2025-06-18 | 17,000 | — | $0 | 17,000 | SEC↗ |
| AURA Aura Biosciences, Inc. | A Award | 2025-06-17 | 2025-06-18 | 13,000 | — | $0 | 23,500 | SEC↗ |
| TRML Tourmaline Bio, Inc. | A Award deriv | 2025-06-04 | 2025-06-06 | 16,800 | — | $0 | 16,800 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 29,946 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 28,877 | — | $0 | 28,877 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 28,877 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 29,946 | — | $0 | 29,946 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-06-27 | 2024-07-01 | 28,877 | — | $0 | 28,877 | SEC↗ |
| AURA Aura Biosciences, Inc. | A Award deriv | 2024-06-20 | 2024-06-24 | 14,500 | — | $0 | 14,500 | SEC↗ |
| AURA Aura Biosciences, Inc. | A Award | 2024-06-20 | 2024-06-24 | 10,500 | — | $0 | 10,500 | SEC↗ |
| INVA Innoviva, Inc. | A Award deriv | 2024-06-17 | 2024-06-20 | 10,000 | — | $0 | 22,500 | SEC↗ |
| INVA Innoviva, Inc. | A Award | 2024-06-17 | 2024-06-20 | 13,923 | — | $0 | 44,096 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award deriv | 2024-06-12 | 2024-06-14 | 3,789 | — | $0 | 3,789 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award | 2024-06-12 | 2024-06-14 | 2,499 | — | $0 | 2,499 | SEC↗ |
| TRML Tourmaline Bio, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TRML Tourmaline Bio, Inc. | A Award deriv | 2023-10-23 | 2023-10-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TRML Tourmaline Bio, Inc. | D To issuer deriv | 2023-10-19 | 2023-10-23 | 20,500 | — | $0 | 0 | SEC↗ |
| TRML Tourmaline Bio, Inc. | A Award | 2023-10-19 | 2023-10-23 | 518 | — | $0 | 518 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award deriv | 2023-06-15 | 2023-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SQZ SQZ Biotechnologies Co | A Award deriv | 2023-06-14 | 2023-06-15 | 39,875 | — | $0 | 39,875 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | A Award deriv | 2023-06-13 | 2023-06-14 | 20,500 | — | $0 | 20,500 | SEC↗ |
| AURA Aura Biosciences, Inc. | A Award deriv | 2023-06-07 | 2023-06-09 | 16,000 | — | $0 | 16,000 | SEC↗ |
| INVA Innoviva, Inc. | A Award deriv | 2023-05-22 | 2023-05-24 | 10,000 | — | $0 | 12,500 | SEC↗ |
| INVA Innoviva, Inc. | A Award | 2023-05-22 | 2023-05-24 | 16,495 | — | $0 | 30,173 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award deriv | 2022-06-16 | 2022-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SQZ SQZ Biotechnologies Co | A Award deriv | 2022-06-15 | 2022-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AURA Aura Biosciences, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 16,000 | — | $0 | 16,000 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-13 | 14,501 | — | $0 | 14,501 | SEC↗ |
| AURA Aura Biosciences, Inc. | A Award deriv | 2021-10-28 | 2021-10-29 | 16,000 | — | $0 | 16,000 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award deriv | 2021-07-28 | 2021-07-30 | 68,500 | — | $0 | 68,500 | SEC↗ |
| SQZ SQZ Biotechnologies Co | A Award deriv | 2021-06-15 | 2021-06-17 | 10,500 | — | $0 | 10,500 | SEC↗ |
| SQZ SQZ Biotechnologies Co | A Award deriv | 2020-10-29 | 2020-10-30 | 42,120 | — | $0 | 42,120 | SEC↗ |
| MYOS MYOS Corp | A Award deriv | 2015-01-12 | 2015-01-12 | 4,000 | — | $0 | 4,000 | SEC↗ |
| MYOS MYOS Corp | A Award deriv | 2014-03-10 | 2014-03-12 | 2,500 | — | $0 | 2,500 | SEC↗ |
| MYOS MYOS Corp | A Award deriv | 2014-02-03 | 2014-02-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| MYOS MYOS Corp | A Award deriv | 2013-10-08 | 2013-10-10 | 150,000 | — | $0 | 150,000 | SEC↗ |
| MYOS MYOS Corp | A Award deriv | 2013-07-01 | 2013-07-24 | 150,000 | — | $0 | 150,000 | SEC↗ |
| MYOS MYOS Corp | A Award deriv | 2013-04-01 | 2013-07-24 | 150,000 | — | $0 | 150,000 | SEC↗ |
| MYOS MYOS Corp | A Award deriv | 2013-02-08 | 2013-02-15 | 250,000 | — | $0 | 250,000 | SEC↗ |
| MYOS MYOS Corp | A Award | 2013-02-08 | 2013-02-15 | 100,000 | — | $0 | 200,000 | SEC↗ |